Non-histone lactylation in cancer: current advances and clinical implications - Top-Institutions - MDSpire

Non-histone lactylation in cancer: current advances and clinical implications

  • By

  • Yang, Robert Le

  • Liang, Yiran

  • May 18, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Cancer Research

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Cancer Biology

  • #3

    National Cancer Institute
    National Cancer Institute

    Bethesda, Maryland

    Key Differentiators

    • Oncology
    • Clinical Trials

  • #4

    Medical College of Wisconsin
    Medical College of Wisconsin

    Milwaukee, Wisconsin

    Key Differentiators

    • Oncology
    • Transplantation

  • #5

    Princess Margaret Cancer Centre
    Princess Margaret Cancer Centre

    Toronto, Ontario

    Key Differentiators

    • Oncology
    • Clinical Research

Original Source(s)

Non-histone lactylation in cancer: current advances and clinical implications

  • by Yang, Robert Le, Liang, Yiran

  • May 18, 2026

Related Content

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications

Gastric-type endocervical adenocarcinoma with Peutz-Jeghers syndrome: a case report and literature review

VANGL1 links angiogenesis–stemness programs and tumor microenvironment remodeling: a pan-cancer, multi-omics study with translational validation